:::

詳目顯示

回上一頁
題名:AIDS、省府虛級化、與B型肝炎疫苗--科學知識在臺灣的一種社會建構歷程
書刊名:新史學
作者:林崇熙 引用關係
作者(外文):Lin, Chung-hsi
出版日期:1997
卷期:8:1
頁次:頁89-134
主題關鍵詞:科學知識社會建構B型肝炎疫苗科學史臺灣Scientific knowledgeSocial constructionHepatitis B vaccineHistory of scienceTaiwan
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(1) 專書(2) 專書論文(1)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:242
  • 點閱點閱:274
     「科學」常被塑造成客觀、理性、追求真理的純真形象。然而,如果我們將科學 知識的黑箱打破,而去考察其形成過程,將可發現:科學家並不是唯一的科學知識生產者; 各式各樣的社會成員都有可能透過不同形式的管道「合法」地參與科學知識的形塑過程。本 文以 B 型肝炎血獎疫苗在一九九0年代初期臺灣的生命歷程, 考察相關於忐疫苗的科學知 識如何在政策考量、經濟活動、政治利益的糾葛中,不斷地被重新塑造;最後何以將在臺灣 以至全世界十多年來評價優良的 B 型肝炎血漿疫苗以「安全」為由而捨棄。 在此過程中, 當我們看到所謂「政治活動」、「經濟活動」等是內在於科學知識的生產過程時,傳統所謂 的科學理性、客觀、中性等概念就變成只是一種策略運用了。
     Examining the controversy regarding the asfety issues of the hepatitis B vaccines, this paper discusses how policy considerations, economic activities , and political interests shaped and reshaped the knowledge regarding the hepati tis B vaccines in Taiwan during the early 1990s. Quite contrary to the current image of science as an objective, rational, and truth-researching activity, I argue that both political activities and economic considerations are important dimensions of scientific practice. If we open the blackbox of scientific knowledge and investigate its formation process, we soon find that scientists are not the sole producers of scientific knowledge; that is, various participants besides scientists may enter scientific practice by bringing in a rang of ethical, economic, cultural, political, and technical issues and creat a controversy. Since various participants can simultaneously enlist contradictory scientific knowledge in their argument against each other, the privilege of scientific knowledge decreases; that is, scientific knowledge is not the sole arbitrator of a scientific controversy. When political negotiations, economic interests, and scientific arguments operate simultaneously within this controversy, they create new scientific knowledge regarding the hepatitis B vaccines.
期刊論文
1.Beasley, R. P.、Hwang, L. Y.、Lin, C. C.、Chien, C. S.(1981)。Hepatocellular Carcinoma and Hepatitis B Virus: A Prospective Study of 22707 Men in Taiwan。The Lancet,2,1129-1133。  new window
2.Szmuness, Wolf(1978)。Hepatocellular Carcinoma and Hepatitis B Virus: Evidence for a Causal Association。Progress in Medical Virology,24,40-69。  new window
3.王振寰(19890300)。臺灣的政治轉型與反對運動。臺灣社會研究季刊,2(1),71-116。new window  延伸查詢new window
4.林朝京(1981)。認識病毐肝炎之防治。健康教育,47,2。  延伸查詢new window
5.劉瓊宇(1981)。克服肝炎。大眾醫學,31,11。  延伸查詢new window
6.李悌元(1981)。病毐性肝炎流行病學。健康教育,47,8。  延伸查詢new window
7.Juei-Low, Sung、DS, Chen(1980)。Maternal Transmission of Hepatitis B Surface Antigen in Patients With Hepatocellular Carcinoma in Taiwan。Scandinavian Journal of Gastroenterology,15,321。  new window
8.Beasley, R. Palmer(1982)。Hepatitis B Virus as the Etiologic Agent in Hepatocellular Carcinoma-Epidemiologic Consdiertions。Hepatology,2(2),21s。  new window
9.Beasley, R. Palmer、Hepatitis, B. Virus(1988)。Hepatitis B Virus: The Major Etiology of Hepatocellular Carcinoma。Cancer,61(10),1942-1956。  new window
10.Lin, Tong-ming、WT, Tsu、CJ, Chen(1986)。Mortility of Hepatoma and Cirrhosis of Liver in Taiwan。British Journal of Cancer,54,969。  new window
11.Chen, Chien-Jen、KY, Liang、Chang, A. S.(1991)。Effects of Hepatitis B Virus, Alcohol Dirnking, Cigarette, Smoking an dFamilial Tendency on Hepathcellular Carcinoma。Hepatology,13(3),398。  new window
12.Lin, Tong-ming、CJ, Chen、SF, Tsai、Tsai, T. H.(1988)。Tepatoma in Taiwan。Journal of National Public Health Association,8(2),91。  new window
13.于明暉、陳建仁(1992)。肝細胞癌之流行病學特徵與危險因子。臺灣公共衛生雜誌,11(3),165。  延伸查詢new window
14.Chen, Chien-Jen、MW, Yu、Wang, H. Y.(1993)。Multiple Risk Factors of Hepatocellular Carcinoma: A Cohort Study of 13,737 Male Adults in Taiwan。Journal of Gastroenterlogy and Hepatology,8,S83。  new window
15.宋瑞樓(1985)。學術生涯四十四年。景福醫訊,2(2),3。  延伸查詢new window
16.Chen, Ding-shinn、Hsu, HM、Sung, J. L.(1987)。A Mass Vaccination Program in Antigen-Carrier Mothers。Journal of American Medical Association,257(19),2597。  new window
17.Center for Disease Control(1982)。Inactivated Hepatitis B Virus Vaccine。Morbidity and Mortality Weekly Report,31(24),317。  new window
18.Center for Disease Control(1982)。Hepatitis B Virus Vaccine Safety: Report of an Inter -Agency Group。Morbidity and Mortality Weekly Report,31(34),464。  new window
19.Center for Disease Control(1983)。Trends: Safety of Hepatitis B Virus accine。MMWR,249,14。  new window
20.Center for Disease Control(1984)。Hepatitis B Vaccine: Edidence Confirming Lack of AIDS Transmission。MMWR,33(49),685。  new window
21.Center for Disease Control(1985)。Hepatitis B Vaccine: Evidence Confirming Lack of AIDS Transmission。MMWR,253(1),21。  new window
22.Francis, Donald P.、PM, Feorino、S., McDougal、D., Warfield(1986)。The Safety of the Hepatitis B Vaccinne。JAMA,256(7),869。  new window
23.Grady, George F.(1986)。The Here and Now of Hepatitis B Immunization。The New England Journal of Medicine,315(4),250。  new window
24.Grady, George F.(1986)。The here and Now of Hepatitis B Immunization。The New England Journal of Medicine,315,4。  new window
25.Linnebank, Geert(1983)。Biogen's Inside Track。Nature,304,297。  new window
26.Scolnick, Edward M.、MacLean, A. A.、DJ, West、WJ, McAleer(1984)。Clinical Evaluation in Healthy Adults of a Hepatitis B Vacine Made by Recombinant DNA。JAMA,251,21。  new window
27.Dandolos, E.、SC, Richardson、G., Papaevangelou(1985)。Safety and Immunogenicity of a Recombinant Hepatitis B Vaccine。Journal of Medical Virology,17,57。  new window
28.Stevens, Cladd E.、PE, Taylor、MI, Tong、PT, Toy(1987)。Yeast-Recombinant Hepatitis B Vaccine: Efficacy with Hepatitis B Immune Globulin in Prevention of Perinatal Hepatitis B Virus Transmission。JAMA,257(19),2612。  new window
29.Castro, Janice(1986)。A Breakthrough for Biotech: The First Genetically Enginnered Vaccine for Humans Is Approved。Time,4,52。  new window
30.Hoppe, Richard、Hamilton, Joan O'C(1986)。A Shot in the Arm for Vaccine Makers。Business Week,4,29。  new window
31.Stevens, Cladd E.、PE, Taylor、MI, Tong、PT, Toy(1987)。Yeast-Recombinant Hepatitis B Vaccine: Efficacy with Hepatitis B Immune Globulin in Prevention of Perinatal Hepatitis B Virus Transmission。JAMA,257,2612。  new window
32.Hollinger, Blaine F.(1987)。Hepatitis B Vaccines: To Switch or Not to Switch。JAMA,257,2634。  new window
33.Castro, Janice(1986)。A Breakthrough for Biotech: The First Genetically Engineered Vaccine for Humans Is Approved。Time,4,52。  new window
34.Stehlin, Dori(1990)。Hepatitis B: Available Vaccine Safe But Underused。FDA Consumer,52。  new window
35.Scolnick, Edward M.、MacLean, A. A.、DJ, West、WJ, McAleer(1984)。Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA。JAMA,251(21),2812。  new window
36.(1984)。民生報。民生報。  延伸查詢new window
37.(1991)。臺灣省議會公報。臺灣省議會公報,68(15),2166。  延伸查詢new window
38.Chan, Cho-yu、Lee, S. D.、Tsai, YT、Lo, K. J.(1991)。Booster Response to Recoombinant Yeast-Derived Hepatitis B Vaccine in Vaccines Whose Anti-HBs Response Initially Elicited by a Plasma-Derived Vaccine。Vaccine,9,765。  new window
會議論文
1.Juei-Low, Sung、DS, Chen(1976)。Hepatitis B Surface Antigen and Antibody in Liver Disease in Taiwan。Singapore。265。  new window
學位論文
1.林崇熙(1989)。台灣科技政策的歷史研究 (1949-1983年)(碩士論文)。國立清華大學。  延伸查詢new window
2.Lin, Chung-hsi(1994)。The Politics of Scientific Development in Taiwan: The Hepatitis B Control Program。  new window
圖書
1.MOFA(1979)。The Republic of China's Relations with the World。The Republic of China's Relations with the World。Taipei。  new window
2.行政院國家科學委員會(1978)。行政院科學技術會議實錄。行政院科學技術會議實錄。臺北。  延伸查詢new window
3.若林正丈、洪金珠、許佩賢(1994)。臺灣--分裂國家與民主化。臺北:新自然主義。  延伸查詢new window
4.蕭全政(198904)。臺灣地區的新重商主義。臺北:業強出版社。  延伸查詢new window
5.徐正光、宋文里(1989)。臺灣新興社會運動。巨流圖書股份有限公司。new window  延伸查詢new window
6.行政院衛生署(1981)。衛生統計II─死亡統計。衛生統計II─死亡統計。臺北。  延伸查詢new window
7.Chen, Chien-Jen、YC, Chang、SF, Tsai(1988)。Epidemiological Studies of Multiple Risk Factors in Hepatocellular Carcinoma in Taiwan。Viral Hepatitis and Liver Disease。New York。  new window
8.行政院衛生署(1980)。衛生統計II─死亡統計。衛生統計II─死亡統計。臺北。  延伸查詢new window
9.Cheng, Tun-Jen、Haggard, Stephen(1987)。Newly Industrialzing Asia in Transition。Newly Industrialzing Asia in Transition。C. A.。  new window
10.行政院科技顧問組(1987)。生物技術。生物技術。臺北。  延伸查詢new window
11.行政院科技顧問組(1994)。生物技規畫小組報告。生物技規畫小組報告。臺北。  延伸查詢new window
12.許須美(1990)。臺灣地區B型肝炎流行病學與預防注射的推動及評估。臺灣地區B型肝炎流行病學與預防注射的推動及評估。臺北。  延伸查詢new window
13.Stevens, Taylor P. E.、Tong, Myron J.、Toy, P. T.(1984)。Hepatitis B Vaccine: An Overview。Viral Hepatitis and Liver Disease。Orlando。  new window
其他
1.續伯雄(1991)。臺灣日報,臺南。  延伸查詢new window
2.(1984)。中國時報。  延伸查詢new window
3.行政院。加強B型肝炎防治計畫。  延伸查詢new window
4.(1983)。行政院肝炎防治顧問委員第一次會議記錄。  延伸查詢new window
5.行政院衛生署(1981)。預防乙(B)型肝炎。  延伸查詢new window
6.行政院衛生署。加強B型肝炎防治計畫。  延伸查詢new window
7.(1982)。遺傳工程研討會會議記錄。  延伸查詢new window
8.藍忠孚(1982)。簡胤博士對B型肝炎防治計畫之看法。  延伸查詢new window
9.(1986)。Development of Pharmaceutical Industry in Taiwan, R. O. C. by Huang Weng-foung。  new window
10.(1984)。民生報73.8.5剪報─引進第二代肝炎疫苗計畫應由肝炎防治委員會評估。  延伸查詢new window
11.(1984)。University of Washington Medical Research Unit Applying for Clinical Trial of the Recombinant DNA Hepatits B Vaccine in Taiwan, URMRU/RPB: CT 84-153。  new window
12.(1983)。B型肝炎預防注射實施計畫。  延伸查詢new window
13.(1984)。保生製藥公司B型肝炎疫苗設廠投資計畫。  延伸查詢new window
14.(1984)。衛生署肝炎防治委員會臨床及充行病學組七十三年度第三次小組會議記錄。  延伸查詢new window
15.(1984)。衛生署肝炎防治委員會七十三年度第四次會議計錄。  延伸查詢new window
16.(1985)。研討保生製藥股份有限公司型肝炎血漿疫苗黑猩猩安全試驗研究言畫會議記錄。  延伸查詢new window
17.(1984)。我國自製B型肝炎 疫苗發展簡幸會議記錄。  延伸查詢new window
18.(1987)。國產血漿B型肝炎疫苗核准登記說明。  延伸查詢new window
19.(1988)。審議HB-VAXII暨Engerix-B臨床確認試驗計畫第二次小組會議記錄。  延伸查詢new window
20.(1991)。聯合報,臺北。  延伸查詢new window
21.(1991)。自由時報,臺北。  延伸查詢new window
22.(1991)。建國日報。  延伸查詢new window
23.(1991)。青年日報。  延伸查詢new window
24.(1991)。大成報。  延伸查詢new window
25.(1991)。臺灣新生報,臺北。  延伸查詢new window
26.(1991)。聯合晚報。  延伸查詢new window
27.(1990)。中央日報:讀書週刊,臺北。  延伸查詢new window
28.(1988)。衛生署肝炎防治委員會七十七年度第三次會議記錄。  延伸查詢new window
29.(1987)。立法院公報,臺北。  延伸查詢new window
30.衛生署(1990)。「不同廠牌之型肝炎 疫苗混合使用之免疫效果研究」研究方針研討會會議記議。  延伸查詢new window
31.保生公司(1992)。致股東書。  延伸查詢new window
32.行政院(1990)。行政院肝炎防治顧問委員會第八次會議記錄。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關著作
 
QR Code
QRCODE